Celldex Therapeutics Inc

2 ott 2026, 20:00 UTC

Celldex Therapeutics Inc shares fell more than two percent, reversing earlier gains and remaining significantly below its 20-day moving average.

1 ott 2026, 19:46 UTC

Celldex Therapeutics Inc shares fell, continuing a trend from Wednesday, amid a slight downturn in the State Street SPDR S&P Biotech ETF.

30 set 2026, 23:45 UTC

Celldex Therapeutics Inc is rising in after-market trading, gaining ground since Wednesday's close, despite remaining below its 20-day moving average.

29 set 2026, 19:46 UTC

Celldex Therapeutics Inc shares are higher today after positive feedback on Barzolvolimab, with analysts raising the price target to $64 per share.

28 set 2026, 22:35 UTC

Celldex Therapeutics Inc is trading modestly higher in after-market hours, recovering from an early dip but remains below its 20-day moving average.

25 set 2026, 19:20 UTC

Celldex Therapeutics Inc shares fell sharply after an early high, currently trading below Thursday's close and notably under its 20-day moving average.

23 set 2026, 20:02 UTC

Celldex Therapeutics shares fell sharply amid safety concerns from its Phase 3 CSU study, despite Overweight ratings from Morgan Stanley and Leerink Partners.

22 set 2026, 23:06 UTC

Celldex Therapeutics Inc is seeing a modest increase in after-market trading, recovering from an earlier session low and gaining since Tuesday's close.

21 set 2026, 20:01 UTC

Celldex Therapeutics Inc shares fell sharply, diverging from recent gains as the biotechnology sector shows varied performance.

18 set 2026, 20:02 UTC

Celldex Therapeutics Inc shares fell sharply, remaining well below their 20-day moving average after a notable high earlier in the session.

17 set 2026, 20:07 UTC

Celldex Therapeutics Inc is modestly higher in Thursday's session, rebounding from an earlier pullback, amid a boost from positive developments in the biotech sector.

16 set 2026, 20:10 UTC

Celldex Therapeutics Inc is advancing in Wednesday's market session, showing modest gains since Tuesday, despite pulling back from earlier session highs.

15 set 2026, 20:07 UTC

Celldex Therapeutics Inc shares are lower amid sector-wide weakness in biotechnology, influenced by rising yields and Federal Reserve concerns.

14 set 2026, 20:03 UTC

Celldex Therapeutics Inc shares are higher today, with no specific news identified. Rising crude oil prices contribute to broader market inflation concerns ahead of the Fed's decision.

11 set 2026, 20:08 UTC

Celldex Therapeutics Inc shares are lower today, continuing a five-session decline. The stock is trading significantly below its 20-day moving average.

10 set 2026, 19:26 UTC

Celldex Therapeutics Inc shares are lower, reflecting bearish sentiment in the biotechnology sector. The stock remains below its 20-day moving average.

8 set 2026, 20:07 UTC

Celldex Therapeutics Inc shares are lower today, reflecting ongoing performance weakness amid speculation about a potential Federal Reserve interest rate hike.

28 ago 2026, 20:03 UTC

Celldex Therapeutics Inc. shares are lower today, breaking a trend of higher closes. Broader market conditions may be influencing this shift.

24 ago 2026, 20:06 UTC

Celldex Therapeutics is trading higher, reflecting positive sentiment in the biotechnology sector despite no specific company news. Overall movement remains higher since Friday's close.

21 ago 2026, 19:26 UTC

Celldex Therapeutics Inc. shares are higher, maintaining above the 20-day moving average amid a broader market rebound and shifts toward safe-haven assets.

20 ago 2026, 20:01 UTC

Celldex Therapeutics shares are lower as biotechnology stocks face pressure, reflecting a notable decline since Wednesday. Earlier, shares briefly peaked before dropping sharply.

19 ago 2026, 19:26 UTC

Celldex Therapeutics Inc is trading higher during Wednesday's session, maintaining gains since Tuesday's close despite earlier intraday fluctuations.

18 ago 2026, 19:36 UTC

Celldex Therapeutics Inc. shares are lower today amid broader market concerns, including rising treasury yields and inflation fears, despite remaining above the 20-day moving average.

17 ago 2026, 19:16 UTC

Celldex Therapeutics Inc. shares are lower today, retracing from earlier gains amid broader market concerns over economic growth following recent U.S. retail sales data.

14 ago 2026, 20:06 UTC

Celldex Therapeutics Inc shares are lower today amid mixed market sentiment following a decline in U.S. retail sales for July.

13 ago 2026, 20:06 UTC

Celldex Therapeutics shares are lower today, continuing a decline since Wednesday amid rising initial jobless claims in the U.S.

12 ago 2026, 19:56 UTC

Celldex Therapeutics Inc is higher today, maintaining a positive trend after closing up in the last seven sessions. The stock pulled back slightly from an earlier peak.

11 ago 2026, 20:06 UTC

Celldex Therapeutics Inc shares are higher today, marking six consecutive sessions of gains. The stock remains significantly above its 20-day moving average.

10 ago 2026, 19:16 UTC

Celldex Therapeutics shares are higher as Barclays and Morgan Stanley raise price targets to $53.00 and $46.00, respectively, maintaining overweight ratings.

7 ago 2026, 19:11 UTC

Celldex Therapeutics shares are lower despite Morgan Stanley and Barclays raising price targets to $46 and $53, respectively. Broader market volatility persists.